Navigation Links
Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science
Date:2/4/2009

ARMSTRONG, Iowa, Feb. 4 /PRNewswire-FirstCall/ -- Art's Way Manufacturing, Inc. (Nasdaq: ARTW), announces its wholly owned subsidiary, Art's Way Scientific, Inc. - Buildings For Science - has launched a new web site - http://www.buildingsforscience.com/ The new site, reflective of the company's new brand image, is graphically enhanced, clean and more user-friendly.

Art's Way Scientific (http://www.buildingsforscience.com) is a leading supplier of custom-designed modular laboratories for biocontainment, animal science, public health, and biomedical & security requirements.

Dan Palmer, General Manager of Art's Way Scientific - Buildings For Science - said, "Many of our clients and prospective customers we have looking at our website are scientific researchers and academic facility managers who tend to be very internet savvy when it comes to finding the appropriate suppliers for their specific building needs. It was important for us to develop a website that showcases our product knowledge, current information and competitive edge. One very important element of the new web site is that it hosts an improved technical library, which includes case studies and references."

J. Ward McConnell, Jr., Executive Chairman of the Board, said, "The goal of Art's Way Scientifics' new web site is to provide a one-stop technology resource that will enhance information exchange, continue industry education, and initiate a running dialogue about advancements in modular laboratory technology, design and construction. We are committed to providing our customers with a simple site providing the latest information to help them make informed decisions."

About Art's Way Scientific, Inc. - B
'/>"/>

SOURCE Art?s Way Manufacturing, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medical Machines Online Announces Release of a Brand New Philips HeartStart AED Defibrillator
2. Scopus to Expand Arts & Humanities Coverage
3. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
4. Tips on how to build a better home for biological parts
5. Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
6. Tips on how to build a better home for biological parts
7. Gerresheimer Starts Process to Sell off its Business Segment of Technical Plastics
8. Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
9. AMT Starts Collaboration With St. Jude Childrens Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
10. Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
11. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE: ... technology platform company serving the global pharmaceutical, biotechnology, ... Investigational New Drug (IND) application for WuXi MedImmune,s ... been accepted for review by the China Food ... September 2012, MedImmune, the global biologics research and ...
(Date:3/26/2015)... WARREN, N.J., March 26, 2015  Roka Bioscience, ... company focused on providing advanced testing solutions for ... financial results for the three months and full ... Quarter 2014 Financial Results:Revenue for the quarter ended ... $689,000 for the fourth quarter of 2013 and ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The Market ... formed a strategic alliance with Designing Gig LLC to ... clients. , “Forging this alliance with Designing ... Now we can extend a comprehensive, end-to-end, digital solution ... strategy, and execution,” said Chuck Miller, president of The ...
(Date:3/26/2015)... Corporation (NASDAQ: NEOG ) announced today that its ... which ended Feb. 28, increased 13% to $7,454,000, when ... in the current quarter were $0.20, compared to $0.18 ... over prior year to $24,142,000, or $0.65 per share, ... same period a year ago. Revenues for ...
Breaking Biology Technology:Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 2Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 5Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 7The Market Element LLC and Designing Gig LLC Form Strategic Alliance 2Neogen reports 13% increase in net income 2Neogen reports 13% increase in net income 3Neogen reports 13% increase in net income 4Neogen reports 13% increase in net income 5Neogen reports 13% increase in net income 6Neogen reports 13% increase in net income 7Neogen reports 13% increase in net income 8
... LLC ( http://www.trimarkpublications.com ), a global leader in the ... newly published Regenerative Medicine Markets report that ... $3 billion in 2010 and is expected to reach ... to treat injuries and diseases with specially-grown tissues by ...
... YOKOHAMA, Japan, September 1, 2010 ... ... ... keyed by longUrl, so we need to grab the first one. for (var r in data.results) { ...
... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var ... first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var key in ...
Cached Biology Technology:Regenerative Medicine Market Expected to Reach $4.5 Billion by 2014 2ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 2ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 3ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 4ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 5ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 6Medisafe 1 Technologies Announces 1-5 Stock Dividend 2Medisafe 1 Technologies Announces 1-5 Stock Dividend 3Medisafe 1 Technologies Announces 1-5 Stock Dividend 4Medisafe 1 Technologies Announces 1-5 Stock Dividend 5Medisafe 1 Technologies Announces 1-5 Stock Dividend 6
(Date:3/10/2015)... -- Continuing its 167-year history of offering the Best, the ... Eye Scanning Password Authenticator , a device that confirms ... or sensitive data. Employing the same biometric ... device has a small camera that scans and saves ... them into an encrypted ID that cannot be forged ...
(Date:3/10/2015)... March 10, 2015  NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the ... smart wallet has been named the "Number One ... Rethink Modern ( http://www.rethinkmodern.com/ ) is ... your home and lifestyle that have a unique function ...
(Date:3/3/2015)... March 3, 2015 Cryoport, Inc. ... advanced cryogenic logistics solutions for the life ... cells, cell lines, clinical research organizations, vaccine ... announced the expansion of its relationship with ... ("Fred Hutch") Clinical Research Division with the ...
Breaking Biology News(10 mins):Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
... cancer,patients have an abnormality in a specific cell ... pathway may be,especially effective for treating the disease, ... D. Anderson Cancer Center.", , A clearer picture ... 3 kinase (PI3K),pathway to breast cancer development, says ...
... large, multisite trial designed to examine the safety ... to prevent HIV infection has opened to volunteer ... of Allergy and Infectious Diseases (NIAID), part of ... among various research institutions in Africa and the ...
... brain-clogging deposits that cause such disorders as Alzheimer's ... out how to capture and "micromanipulate" the single ... aim is to understand the detailed assembly process ... basic understanding, they said, could lead to approaches ...
Cached Biology News: MetaChip provides quick, efficient toxicity screening of potential drugs 2Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimer's, Parkinson's Disease 2
... and easy to use Ascent ... all members of the Ascent ... a clear and easy-to-follow approach ... user-friendly and highly sophisticated data ...
... Lambda Protein Phosphatase ... Mn2+-dependent protein phosphatase with ... threonine and tyrosine residues. ... amino-acid product of the ...
Angiotensin Converting Enzyme [Porcine Kidney, ACE, Peptidyl-dipeptidase A]...
Oven mesh sheets, large, 23 x 23cm, pack of 5...
Biology Products: